However, in the past 2.5 years, several SARS-CoV-2 lineages emerged that acquired S protein mutations, which reduced the sensitivity to neutralization by antibodies elicited upon vaccination with these COVID-19 vaccines [2,9,12,30,31,32,33]. This evidence concerns the gene PROS1 and COVID-19.